These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19229504)

  • 1. [Drug-induced lupus erythematosus tumidus during treatment with adalimumab].
    Sohl S; Renner R; Winter U; Bodendorf M; Paasch U; Simon JC; Treudler R
    Hautarzt; 2009 Oct; 60(10):826-9. PubMed ID: 19229504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents.
    Dalle Vedove C; Simon JC; Girolomoni G
    J Dtsch Dermatol Ges; 2012 Dec; 10(12):889-97. PubMed ID: 22937775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous lupus erythematosus induced by adalimumab.
    Vezzoli P; Violetti SA; Serini SM; Muratori S; Berti E; Crosti C
    J Dermatol; 2011 Mar; 38(3):283-4. PubMed ID: 21342233
    [No Abstract]   [Full Text] [Related]  

  • 4. Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis.
    West ES; Nanda K; Ofodile O; Rutledge J; Brandling-Bennett HA
    Pediatr Dermatol; 2015; 32(4):e140-4. PubMed ID: 25845414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous reactions to adalimumab administration.
    Downes MR; Prendiville S; Kiely C; Lenane P; Mulligan N
    Ir Med J; 2011 Apr; 104(4):122-3. PubMed ID: 21675098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous lupus erythematosus and anti-TNF-alpha therapy: a case report with review of the literature.
    Levine D; Switlyk SA; Gottlieb A
    J Drugs Dermatol; 2010 Oct; 9(10):1283-7. PubMed ID: 20941956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab-induced cutaneous lupus.
    Sheth N; Greenblatt D; Patel S; Acland K
    Clin Exp Dermatol; 2007 Sep; 32(5):593-4. PubMed ID: 17692063
    [No Abstract]   [Full Text] [Related]  

  • 8. [Subacute cutaneous lupus erythematosus induced by golimumab].
    Blasco-Morente G; Notario-Ferreira I; Rueda-Villafranca B; Tercedor-Sánchez J
    Med Clin (Barc); 2015 Sep; 145(5):226-7. PubMed ID: 25547737
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-induced lupus erythematosus.
    Antonov D; Kazandjieva J; Etugov D; Gospodinov D; Tsankov N
    Clin Dermatol; 2004; 22(2):157-66. PubMed ID: 15234017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
    Lorentz K; Booken N; Goerdt S; Goebeler M
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced lupus with leukocytoclastic vasculitis: a rare expression associated with adalimumab.
    Amarante CF; Acedo LM; Rabay FM; Campos Bdo E; Lira ML; Mandelbaum SH
    An Bras Dermatol; 2015; 90(3 Suppl 1):121-4. PubMed ID: 26312693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.
    Ramos-Casals M; Brito-Zerón P; Muñoz S; Soria N; Galiana D; Bertolaccini L; Cuadrado MJ; Khamashta MA
    Medicine (Baltimore); 2007 Jul; 86(4):242-251. PubMed ID: 17632266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of clinical characteristics of drug-induced cutaneous lupus erythematosus in men.
    Petty AJ; Cardones AR; Marano AL
    J Am Acad Dermatol; 2020 Nov; 83(5):1455-1457. PubMed ID: 32151631
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cutaneous lupus induced by etanercept in rheumatoid arthritis].
    Abourazzak FE; Guggenbuhl P; Perdriger A; Meadeb J; Gando-Cocley N; Chevrant-Breton J; Hajjaj-Hassouni N; Chalès G
    Rev Med Interne; 2008 Sep; 29(9):744-7. PubMed ID: 18676065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cutaneous Lupus Erythematosus-Like Eruption Induced by Hydroxyurea.
    Yanes DA; Mosser-Goldfarb JL
    Pediatr Dermatol; 2017 Jan; 34(1):e30-e31. PubMed ID: 27813209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
    Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
    J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous lupus erythematosus induced by the treatment with tumor necrosis factor antagonists.
    Sifuentes Giraldo WA; Ahijón Lana M; Vázquez Díaz M
    Reumatol Clin; 2013; 9(4):255-6. PubMed ID: 23608052
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis.
    Schneider SW; Staender S; Schlüter B; Luger TA; Bonsmann G
    Arch Dermatol; 2006 Jan; 142(1):115-6. PubMed ID: 16415403
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab.
    Havel J; Aboutalebi S; Doughty L; Wirges M
    J Drugs Dermatol; 2008 Aug; 7(8):796-8. PubMed ID: 18720701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE-inhibitor-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and Lupus erythematosus tumidus.
    Schepis C; Lentini M; Siragusa M; Batolo D
    Dermatology; 2004; 208(4):354-5. PubMed ID: 15178923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.